AF
SURF

Amalgamated Financial’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Amalgamated Financial’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$13K Buy
+4,256
New +$14.9K ﹤0.01% 2854

Other funds holding SURF

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amalgamated Financial's SURF Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Surface Oncology, Inc. Common Stock (SURF) in Q1 2022: 4,256 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #2854 among its holdings.

103 funds tracked by Wall St. Rank hold SURF as of Q1 2022.

  • Amalgamated Financial held 4,256 shares of Surface Oncology, Inc. Common Stock worth $13K as of Q1 2022.
  • Surface Oncology, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • Surface Oncology, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2854 holding.
  • 103 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.